Bioheart Inc. (BHRT) 0.0070 $BHRT Sell Great Basin

New Post Public Reply Private Reply Replies (0) Message Board

Apr 12, 2015 at 5:21 AM

Bioheart Inc. (BHRT) 0.0070 $BHRT

Sell Great Basin Scientific Inc., Penny Stock Newsletter Pumps Don't End Well
Big Banks - at Seeking Alpha - Mon Apr 06, 2:31PM CDT

GNMK: 11.80 (+0.14), GBSN: 2.94 (-0.40), RCAP: 9.39 (-0.35), QDEL: 25.54 (+0.36), CPHD: 56.88 (+0.87), RTGN: 3.60 (+0.31)

Bioheart and Ascyrus Medical Execute Investment Agreement
ACCESSWIRE - Thu Mar 19, 8:31AM CDT
SUNRISE, FL / ACCESSWIRE / March 19, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT) and Ascyrus Medical, LLC, a Florida Limited Liability Corporation are pleased to announce that they have entered into an investment agreement. The investment agreement provides for Bioheart to obtain a consolidating ownership stake in Ascyrus Medical upon the achievement of certain business milestones. Bioheart has through June 30, 2015 to meet its milestone obligations.

Bioheart Touts 2014 Accomplishments; Seeks More in 2015
ACCESSWIRE - Tue Mar 17, 1:27PM CDT
SUNRISE, FL / ACCESSWIRE / March 17, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT), an emerging enterprise in the regenerative medicine / cellular therapy industry is pleased to announce, following the release of its Form 10-K Annual Report, key 2014 accomplishments including but not limited to:

Bioheart Strengthens Management Team with Appointment of Martin E. Schmieg as President of Vetbiologics, Inc.
ACCESSWIRE - Wed Feb 11, 10:18AM CST
SUNRISE, FL / ACCESSWIRE / February 11, 2015 / Bioheart, Inc., a Florida Corporation (BHRT.OB), an emerging enterprise in the regenerative medicine / cellular therapy industry announced today the appointment of Martin E. Schmieg as President of Vetbiologics, Inc., the Company's wholly owned animal health subsidiary.

Bioheart Updates and Diversifies Its Clinical Development Pipeline
ACCESSWIRE - Thu Jan 29, 9:00AM CST
SUNRISE, FL / ACCESSWIRE / January 29, 2015 / Bioheart, Inc., a Florida Corporation (OTCQB:BHRT), an emerging enterprise in the regenerative medicine / cellular therapy industry announced today an update and diversification plan for its clinical development pipeline. The company's update includes a realignment of its cardiovascular product candidates and diversification into the treatment of autoimmune diseases with a first generation, investigational research program to treat Rheumatoid Arthritis (RA).

Bioheart Confirms Date and Access for Shareholder Conference Call
ACCESSWIRE - Wed Jan 28, 9:00AM CST
Strategic Direction for 2015 and Forward to be Highlighted

Bioheart to repurchase shares
Seeking Alpha - at Seeking Alpha - Fri Jan 16, 11:38AM CST

Bioheart Announces Date for Shareholder Conference Call
ACCESSWIRE - Wed Jan 14, 9:00AM CST
Strategic Direction for 2015 and Forward to be Highlighted

Bioheart Board of Directors Authorizes a Repurchase of the Company's Outstanding Common Stock
ACCESSWIRE - Tue Jan 13, 9:01AM CST
SUNRISE, FL / ACCESSWIRE / January 13, 2015 / Bioheart, Inc. (OTCQB:BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies a Florida corporation, today announced that its Board of Directors has approved a share repurchase program authorizing the Company to repurchase outstanding Common Stock when beneficially prudent for the Company and its shareholders.

Bioheart Announces Completion of First Stem Cell Training in Australia
ACCESSWIRE - Mon Dec 22, 9:09AM CST
SUNRISE, FL / ACCESSWIRE / December 22, 2014 / Bioheart, Inc. (BHRT.OB), a biotechnology company focused on the discovery, development and, subject to United States regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces completion of the first stem cell training course to bring regenerative therapies to Australia. (www.usstemcelltraining.com)

Bioheart Announces Joint Venture In Nigeria
ACCESSWIRE - Thu Dec 18, 7:01AM CST
SUNRISE, FL / ACCESSWIRE / December 18, 2014 / Bioheart, Inc. (OTCQB:BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announced today that it has entered into a joint venture with Dr. Prosper Igboeli of Nigeria.

Bioheart Announces Expansion Of Clinical Study For Degenerative Disc Disease
ACCESSWIRE - Mon Nov 17, 7:01AM CST
Untitled Document

Bioheart Announces First Intracoronary Implantation of Adipose Stem Cells in Azerbaijan
ACCESSWIRE - Wed Nov 12, 10:22AM CST
SUNRISE, FL / ACCESSWIRE / November 12, 2014 / Bioheart, Inc. (OTCQB:BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced today that the first successful intracoronary implantation of autologous adipose-derived stem cell (ADSC) was performed to a 70 year-old male patient with ischemic cardiomyopathy by Emrah Anar MD (Chief of Cardiology and Cardiovascular Surgery) in Baku (Azerbaijan) Cardiac Center of Central Military Hospital.

Miami Dade College Names Bioheart CEO, Mike Tomas, to Board of Advisors for New Idea Center
Marketwired - Thu Oct 30, 7:02AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, announced that Mike Tomas, President and CEO, will sit on the board of advisors for Miami Dade College's new Idea Center which will serve as Miami Dade College's hub for entrepreneurship for its 165,000 students. The Idea Center will include a venture incubator, called CREATE, with programming and resources to help nurture and accelerate the entrepreneurial ideas and ventures of students.

Bioheart, Inc. Completes Financing With Magna
Marketwired - Fri Oct 24, 3:00PM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and commercialization of autologous cell therapies, a Florida corporation, is pleased to announce the closing of a common stock purchase agreement for a $3 million Equity Enhancement Program ("EEP"

with a Magna affiliate fund, Magna Equities II, LLC (the "Investor"

. The EEP allows, but does not obligate the Company to issue and sell up to $3,000,000 worth of the Company's common stock to the Investor from time to time, over the 24-month term of the purchase agreement.

Bioheart Announces Partnership in Colombia
Marketwired - Wed Oct 15, 7:05AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and, subject to United States regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces partnership to bring Bioheart regenerative therapies to Colombia.

Bioheart Announces Positive 12 Month Preliminary Data From Phase I Angel Trial
Marketwired - Mon Oct 13, 7:02AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, released today preliminary 12 month data from its phase I ANGEL Trial. Fully funded by Bioheart, the trial is being conducted in Mexico at the Hospital Angeles in conjunction with the Regenerative Medicine Institute (RMI).

Bioheart Announces Successful Grand Opening of Facility in South Africa
Marketwire - Wed Sep 24, 7:01AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and, subject to United States regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces a successful grand opening of the laboratory and clinic in South Africa.

Bioheart Announces Grand Opening of Facility in South Africa
Marketwire - Tue Sep 16, 7:03AM CDT
Bioheart, Inc. (OTCQB: BHRT), a biotechnology company focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of degenerative diseases, announces the grand opening the laboratory and clinic in South Africa.

Bioheart Releases Q2 Financial Information Showing Growth
Marketwire - Thu Aug 07, 7:04AM CDT
Bioheart, Inc. (OTCQB: BHRT) released today financial information based on results from Q2 2014. The financial data shows that Bioheart has grown in product revenues, increased income, reduced debt, and further strengthened the financial standing of the company.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Northern Jet Names Veteran Matthew Harris as CEO

Fresh Leadership at Northern Jet Well, if you didn’t see this coming, you’ve been snoozing on the tarmac. Northern Jet, no stranger to the skies after three decades, just roped in Matthew Harris as their new CEO from October 2, 2026. They're pulling in this hotshot with more than 25 years riding the turbulence of private aviation. And listen to this: his marching...

TA Services Strengthens U.S.-Mexico Freight Operations

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Pushing for National Liver Cancer Awareness in 2026

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

NYSE Texas Redefines the U.S. Capital Markets Landscape

NYSE Texas: Carving a Niche The notion of 'Y'all Street' might seem like a gimmick, but NYSE Texas is pushing a serious agenda with its newly released white paper, 'NYSE Texas and the Reshaping of U.S. Capital Markets.' This is no small feat. Texas is already housing 235 NYSE-listed companies, boasting a colossal combined worth of $4.8 trillion. With 130 of these firms...

Purina Institute Highlights Nutritional Science at WSAVA 2026

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Cure Blindness Project's 770K Screenings for World Sight Day

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Truss Financial Tackles Home Equity Closing Delays

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Karoo Health Leaps Forward with New CCO Breton

Change of Guard in Cardiac Health at Karoo Here's a move that might shake things up in the healthtech sector: Karoo Health just snagged Angela "Angie" Breton as their new Chief Commercial Officer. It's like putting a seasoned captain at the helm right before setting sail on uncharted waters. Breton's not just any captain—she's got a hefty 25 years of experience...

Skandia's Soundproofing Kit Expands to Brazil's Skies

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Bob Evans' Protein Mac & Cheese: Practical Power Play

Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...